Etiological Study of Biliary Strictures in Northeast, India, Endoscopic Assessment and Predictors of Malignancy
Authors/Creators
- 1. Department of Gastroenterology, Gauhati Medical College, Guwahati, Assam
Description
Background: Biliary strictures, whether benign or malignant, pose a significant diagnostic challenge. A detailed analysis of the potential factors affecting the differentiation between benign and malignant biliary strictures was undertaken to enhance the precision and efficiency of diagnostic procedures. Methods: This study examined multiple variables such as stricture length, levels of the biomarker CA 19-9, ALKP and bilirubin, alongside demographic factors such as age and gender. Through a comprehensive analysis, we sought to identify which parameters could most reliably indicate the nature of biliary strictures. Results: Our findings revealed that length of the stricture emerged as a notable factor, with an accuracy of 86.7% in distinguishing benign from malignant strictures. The biomarker CA 19- 9 demonstrated a remarkable efficiency with a predictive accuracy of 89.2%. Furthermore, the levels of serum alkaline phosphatase and serum bilirubin were found to be reliable indicators, with AUC values of 0.78 and 0.82 respectively. Gender appeared to be less significant in predicting malignancy, while age exhibited a strong statistically significant association with malignancy. Conclusion: Our study underscores the importance of a multifaceted approach in diagnosing biliary strictures. The identified markers and parameters can potentially enhance the current diagnostic protocols, facilitating more targeted and effective strategies for managing individuals with biliary strictures.
Abstract (English)
Background: Biliary strictures, whether benign or malignant, pose a significant diagnostic challenge. A detailed analysis of the potential factors affecting the differentiation between benign and malignant biliary strictures was undertaken to enhance the precision and efficiency of diagnostic procedures. Methods: This study examined multiple variables such as stricture length, levels of the biomarker CA 19-9, ALKP and bilirubin, alongside demographic factors such as age and gender. Through a comprehensive analysis, we sought to identify which parameters could most reliably indicate the nature of biliary strictures. Results: Our findings revealed that length of the stricture emerged as a notable factor, with an accuracy of 86.7% in distinguishing benign from malignant strictures. The biomarker CA 19- 9 demonstrated a remarkable efficiency with a predictive accuracy of 89.2%. Furthermore, the levels of serum alkaline phosphatase and serum bilirubin were found to be reliable indicators, with AUC values of 0.78 and 0.82 respectively. Gender appeared to be less significant in predicting malignancy, while age exhibited a strong statistically significant association with malignancy. Conclusion: Our study underscores the importance of a multifaceted approach in diagnosing biliary strictures. The identified markers and parameters can potentially enhance the current diagnostic protocols, facilitating more targeted and effective strategies for managing individuals with biliary strictures.
Files
IJPCR,Vol15,Issue12,Article140.pdf
Files
(379.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:311b187b9f016b0ccf62bca6b40902fe
|
379.9 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-11-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue12,Article140.pdf
- Development Status
- Active
References
- 1. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51(2):660-78. 2. Gupta V, Gupta R, Agarwal S, Kochhar R. Etiology, evaluation, and management of primary and secondary biliary strictures. Gastroenterol Res. 2012;5(4):147-56. 3. Eaton JE, Talwalkar JA. Biliary Strictures: Diagnostic Considerations and Approach. GastroenterolHepatol. 2016;12(10):645-53. 4. Das M, Goswami B, Singh A. Nutritional status and lifestyle practices of the scheduled tribes of the Northeast India. Health PopulNutr. 2018;39(1):11.5. Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. GastrointestEndosc. 2015;81(1):168-76. 6. Kahaleh M, Brijbassie A, Sethi A, Degaetani M, Poneros JM, Loren DE, et al. Multicenter trial evaluating the use of covered selfexpanding metal stents in benign biliary strictures: time to revisit our therapeutic options? J ClinGastroenterol. 2013;47(8):695-9. 7. Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 2013;145(6):1215-29. 8. Tringali A, Lemmers A, Meves V, Terheggen G, Pohl J, Manfredi G, et al. Intraductal biliary and pancreatic ultrasonography: Experts' review and guidelines. World J GastrointestEndosc. 2015;7(14):1109-21. 9. Barr Fritcher EG, Voss JS, Brankley SM, Campion MB, Jenkins SM, Keeney ME, et al. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples. Gastroenterology. 2015;149(7):1813-24. 10. Lim L, Michael M, Mann GB, Gibbs P. Adjuvant therapy in biliary tract cancer: to treat or not to treat? World J Gastroenterol. 2013;19(39):6525-32. 11. Zenouzi R, Weismüller TJ, Hübener S, Schulze K, Bubenheim M, Pannicke N, et al. Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis. ClinGastroenterolHepatol. 2014;12(10):1733-8. 12. Khashab MA, Valeshabad AK, Leung W, Hutfless S, Kim K, Lennon AM, et al. Multicenter experience with performance of ERCP in patients with an indwelling duodenal stent. Endoscopy. 2014;46(3):252- 5. 13. Njei, B., McCarty, T. R., &Varadarajulu, S. (2019). Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointestinal endoscopy, 89(2), 238- 246.e3. 14. Chen, H., Shen, J., Choy, E., Hornicek, F. J., Duan, Z. (2020). Targeting protein kinases to reverse multidrug resistance in sarcoma. Cancer Treatment Reviews, 81, 101931. 15. Navaneethan, U., Hasan, M. K., Lourdusamy, V., &Njei, B. (2018). Comparative effectiveness of pyogenic liver abscess management strategies: A retrospective cohort study. Journal of Gastroenterology and Hepatology, 33(4), 817-823. 16. Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. J., Rushbrook, S. M., Alexander, G. & Pereira, S. P. (2019). British Society of Gastroenterology and UKPSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut, 68(8), 1356-1378. 17. Poruk, K.E., Gay, D.Z., Brown, K., Mulvihill, J.D., Boucher, K.M., Scaife, C.L., Firpo, M.A., Mulvihill, S.J. (2017). The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Current molecular medicine, 17(3), 330-339. 18. Sherwood, P. R., Lytle, L. A., Nilsson, M., &Ptacek, J. T. (2015). Clinical indicators for malignant ventricular arrhythmias in LQTS patients. Journal of Cardiovascular Electrophysiology, 26(4), 466-472. 19. De Moura, D.T., McCarty, T.R., Jirapinyo, P., Ribeiro, I.B., Flumignan, V.K., Ryou, M., Thompson, C.C. (2021). Comparative efficacy of techniques for endoscopic closure of gastrointestinal defects: A systematic review and network metaanalysis. Clinical Gastroenterology and Hepatology, 19(5), 965-983.e5. 20. Ponsioen, C. Y., Arnelo, U., Bergquist, A., Rauws, E. A., Paulsen, V., Cantú, P., ...&Schröder, T. (2016). No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients with Primary Sclerosing Cholangitis. Gastroenterology, 151(3), 448-455.e5. 21. Khan, S. A., Tavolari, S., & Brandi, G. (2019). Cholangiocarcinoma: Epidemiology and risk factors. Liver International, 39(S1), 19-31. 22. Boonstra, K., Weersma, R. K., van Erpecum, K. J., Rauws, E. A., Spanier, B. W., Poen, 23. C., &Beuers, U. (2013). Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology, 58(6), 2045-2055. 24. Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., &Lindor, K. D. (2013). Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology, 145(3), 521- 536. 25. Charatcharoenwitthaya, P., Enders, F. B., Halling, K. C., &Lindor, K. D. (2008). Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology, 48(4), 1106-1117.